 Comparison findings preoperative dipyridamole perfusion scintigraphy intraoperative transesophageal echocardiography implications identification myocardium ischemic risk evidence myocardium potential ischemic risk preoperative dipyridamole perfusion scintigraphy ischemia intraoperative transesophageal echocardiography patients high risk coronary event noncardiac surgery clinical outcome Induced intraoperative wall motion abnormalities common patients myocardial segments preoperative reversible perfusion defect preoperative reversible perfusion defect common patients segments new intraoperative wall motion abnormality patients reversible scintigraphic defect new wall motion abnormality hard perioperative ischemic event Events patients reversible perioperative scintigraphic defect difference significance sample size Intraoperative wall motion abnormalities reversible risk groups findings treatment preliminary data support relation reversible scintigraphic defects perioperative events manifestation ischemic risk relation reversible scintigraphic defects induced intraoperative wall motion abnormalities value intraoperative echocardiography ischemia therapy patients reversible scintigraphic abnormality